Coverage of obesity drugs in health plans and the rapid adoption of artificial intelligence are two areas of change that health plans will face during the coming year. A panel of Avalere experts ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

The Trump administration will decide whether to expand coverage for millions of Americans. By Rebecca Robbins Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Ozempic and Wegovy were notable drugs added ... roughly 5.3 million people with Medicare Part D coverage used these drugs for several conditions ranging from cancer to type 2 diabetes.

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. The negotiations for ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy ... also proposed expanding Medicare coverage to weight loss drugs, which ...

Weight loss drugs Ozempic and Wegovy have been added ... about 5.3 million people with Medicare Part D coverage used these drugs to treat a variety of conditions, such as cancer, type 2 diabetes ...

Those drugs are: Ozempic/Wegovy/Rybelsus ... About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $ ...